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Abstract
Pregnancy-associated malaria (PAM) is expressed in a range of clinical complications that include increased disease severity
in pregnant women, decreased fetal viability, intra-uterine growth retardation, low birth weight and infant mortality. The
physiopathology of malaria in pregnancy is difficult to scrutinize and attempts were made in the past to use animal models
for pregnancy malaria studies. Here, we describe a comprehensive mouse experimental model that recapitulates many of
the pathological and clinical features typical of human severe malaria in pregnancy. We used P. berghei ANKA-GFP infection
during pregnancy to evoke a prominent inflammatory response in the placenta that entails CD11b mononuclear infiltration,
up-regulation of MIP-1 alpha chemokine and is associated with marked reduction of placental vascular spaces. Placenta
pathology was associated with decreased fetal viability, intra-uterine growth retardation, gross post-natal growth
impairment and increased disease severity in pregnant females. Moreover, we provide evidence that CSA and HA, known to
mediate P. falciparum adhesion to human placenta, are also involved in mouse placental malaria infection. We propose that
reduction of maternal blood flow in the placenta is a key pathogenic factor in murine pregnancy malaria and we
hypothesize that exacerbated innate inflammatory responses to Plasmodium infected red blood cells trigger severe placenta
pathology. This experimental model provides an opportunity to identify cell and molecular components of severe PAM
pathogenesis and to investigate the inflammatory response that leads to the observed fetal and placental blood circulation
abnormalities.
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Introduction
It is estimated that more than 50 million pregnancies occur
every year in malaria endemic areas, and approximately half of
these occur in sub-Saharan Africa, where P. falciparum transmission
is most intense. Pregnancy-associated malaria (PAM) is one of the
major public health problems in Africa with a high burden of
maternal and fetal morbidity leading to 100,000 infant deaths per
year [1,2]. Pregnant women show increased malaria susceptibility
and the severity of clinical manifestations are worse [3], both to the
mother and fetuses, when maternal pre-immunition is inexistent or
very low [4].
Together with maternal malaria induced anemia [5,6], parasite
sequestration in the placenta are thought to trigger a pathological
process that contributes to decrease fetal viability and leads to
infant Low Birth Weight (LBW) [7,8], due to both preterm
delivery and/or Intrauterine Growth Retardation (IUGR) [9,10].
LBW (defined as birth weight ,2500 g) is known to be the most
important risk factor for infant mortality [11,12]. The outcomes of
PAM are influenced by different factors in different epidemiologic
settings and are depending on the time of infection during the
pregnancy period. In areas with a high rate of malaria
transmission, infections in early pregnancy are associated with
IUGR and abortions, whereas infections in later pregnancy are
associated with preterm delivery [10,13]. In contrast, pregnant
women living in areas of low endemicity experience higher rates of
abortion and stillbirth, associated to an elevated risk of maternal
mortality [4,13].
It is known that the severity of malaria is related to the capacity
of P. falciparum infected Red Blood Cells (iRBC) to sequester in the
microvasculature of vital organs. Plasmodium falciparum Erythrocyte
Membrane Protein 1 (PfEMP1), a malarial variant antigen on
infected erythrocytes, is involved in the adherence to host cell
receptors. Infected erythrocytes can bind to endothelial receptors
such as CD36 and intercellular adhesion molecule 1 (ICAM-1)
[14]. However, studies on placental malaria have suggested that
glycosaminoglycans (GAG) like chondroitin sulfate A (CSA) and
hyaluronic acid (HA), play important roles as receptors for iRBC
adhesion [13,15,16].
Although malaria in pregnancy has recently attracted many
research efforts, there are ethical and logistic issues that restrict
studies of human malaria infection during pregnancy and the
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understood [17]. Mouse malaria models have clear advantages for
the study of PAM pathology due to the relative short gestational
period that allows a reasonable experimental time frame and to
the availability of a wide variety of immunological and genetic
tools. In addition, recent reports provided detailed anatomy and
physiology analysis of mouse placenta [18–20], a key organ in
PAM pathogenesis and pointed out considerable sharing of cell
and molecular features with the human placenta, including the
hemochorial barrier and the maternal antibody transmission to the
fetus across the placenta [20–23].
Previous studies concerning PAM in rodents have focused in
congenital malaria [24] and in the characterization of placenta
pathology [25,26]. Other studies of rodent malaria in pregnancy
aimed to observe disease dynamics and recrudescence [27–32] and
to analyze pregnancy outcome upon disease drug treatment [33].
A recent report described disturbances in mouse pregnancy
outcome after P. chabaudi infection but did not present pathology
comparable to human placental malaria evoked by P. falciparum
[34]. Despite these attempts, a thorough characterization of a
mouse model reproducing the main features of severe malaria in
pregnancy has not been described.
We revisited the study of severe placenta malaria pathology in
the mouse through an experimental model that uses P. berghei
ANKA-GFP to infect BALB/c mice during pregnancy, resulting in
placenta damage and inflammation, as well as IUGR/LBW. In
addition, we found that P. berghei ANKA-GFP iRBC are able to
bind to receptors present in mouse placental tissues providing the
basis for a pathology trigger of mouse placenta pathology,
comparable to the mechanism proposed for human placental
malaria.
This experimental model captures many pathology features
analogous to severe malaria manifestations in pregnant women
and may provide opportunities to investigate the pathogenesis
mechanisms of malaria in pregnancy and enable experimental
evaluation of PAM interventions strategies.
Materials and Methods
Animals and parasites
The BALB/c mice were bred and maintained in conventional
housing at the Instituto Gulbenkian de Cie ˆncia. Infection
experiments were performed in adult females, between 10–
15 weeks of age. P. berghei ANKA constitutively expressing green
fluorescent protein (P. berghei ANKA-GFP) (15cy1 clone) [35,36]
was kindly provided by Professor Andrew P. Waters (Leiden
University Medical Center, Leiden, The Netherlands). Infected
red blood cells (iRBC) used in experimental infections were
obtained from in vivo passage in BALB/c mice, when the
percentage of iRBC reached approximately 10%. Parasitemia
was measured using flow cytometry analysis as described elsewhere
[37]. All animals were fed with regular diet and all procedures
were in accordance with national regulations on animal experi-
mentation and welfare and were authorized by the Instituto
Gulbenkian de Cie ˆncia animal welfare committee.
Gestation timing and pregnancy monitoring
Detection of the vaginal plug and measurement of body weight
were jointly used to time gestation, as described by Freyre et al.
[38]. Two to three females were put together with one male for
2 days, and examined for the presence of vaginal plug every
morning. The day of finding the vaginal plug was considered as
gestation day one (G1) and pregnancy progression was monitored
every other day by weighting the females. Successful fertilization
was confirmed between G10 and G13 when the animals had an
average increase of 3–4 g in body weight. Thus, weight gain was
taken as sign of pregnancy and abrupt weight loss as indicator of
pregnancy damage or interruption.
Pregnancy experimental infection
Pregnant mice were intravenously (IV) infected between G11
and G13 with 10
6 iRBC, and parasitemia was recorded every
other day. To evidence pathological features of malaria during the
course of pregnancy and in the developing fetus, this infection
period was determined to be the optimal time point as earlier
infections did not allow reaching pregnancy at term (data not
shown), which is consistent with previous reports [26,27,31]. Non-
pregnant infected females or non-infected pregnant females were
used as controls in pregnancy infection experiments as appropri-
ate. Part of the pregnant females (both infected and controls) were
allowed to deliver and the progenies were followed up to weaning.
The other pregnant females were subjected to caesarian section
between G17 and G19 for fetal survival and placenta pathology
observation.
Offspring monitoring
As P. berghei ANKA-GFP infection is lethal in BALB/c mice,
foster mothers were used in newborn post-natal follow-up studies.
Hence, both newborns from infected mothers and newborns from
control mothers were also transferred to foster mothers to avoid
weight bias due to differential maternal nourishment. The
newborns were weighted every other day.
Fetal survival evaluation
Between G17 and G19, pregnant females were killed by CO2
narcosis, their spleens were weighted, the uterus was examined
and the number of fetuses and resorptions were recorded.
Resorptions were identified as small implants with no discernible
fetus and placenta, corresponding to embryos that died before
complete placenta vascularization. The fetuses were extracted
from their amniotic envelop and viability was immediately
evaluated by prompted movement reaction to touching with
pliers. The lack of reactive movement indicated that the fetus had
recently died and was considered an abortion. Macerated pale
white fetuses were dead and were also recorded as abortions.
Fetuses and placentas were separately weighted. Non-aborted
fetuses were killed combining CO2 narcosis and hypothermia.
Tissue preparation and histopathological analysis
Placentas from infected and non-infected females were treated
in a similar way. Placentas were separated in two halves, one half
was fixed in 1.6% paraformaldehyde with 20% sucrose for further
processing and the other half collected for RNA extraction.
Paraffin-embedded non-consecutive placenta sections were stained
with hematoxylin-eosin (HE) and examined under a light
microscope (Leica DM LB2, Leica Microsystems). For histological
and morphometric analysis, placental sections were examined in a
blind fashion.
Immunohistochemistry
Fixed placenta samples were washed in PBS with 15% sucrose
overnight, soaked in Tissue-TekH (Sakura) and frozen in dry ice.
For immunohistochemistry staining, freshly made frozen sections
(6 mm thick) were rinsed in PBS for 30 minutes and blocked with
1% bovine serum albumin (BSA). To enhance parasite GFP signal,
we used rabbit polyclonal anti-GFP antibody (Molecular Probes)
and goat anti-rabbit antibody conjugated with Alexa488 (Molec-
ular Probes). To identify macrophages/monocytes we used anti-
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followed by incubation with Rhodamin-Avidin D (Vector
Laboratories). Nuclei were stained with DAPI (Invitrogen) and
coverslips were mounted with aqueous mounting media (Mowiol
4-88, Calbiochem). Stained sections were examined under
fluorescence microscopy (Leica DMRA2, Leica Microsystems).
Morphometric analysis
HE stained placental sections were analyzed for vascular space
quantification. In each section, 5 randomly selected microscopic
fields in the labyrinthine region (magnification640) were acquired
at 12806960 resolution, using a color video camera (Evolution
TM
MP color, Media Cybernetics) connected to a light microscope
(Leica DM LB2, Leica Microsystems). We implemented an image
analysis routine using ImageJ (ImageJ 1.37v, National Institutes of
Health). Briefly, after acquisition, the images underwent an
automated light analysis procedure where noise removal was
applied to ensure color and image quality standardization across
sections and specimens. The images were given a color threshold
to cover the area corresponding to blood spaces lumen. The
coverage percentage was calculated as the ratio between the
number of pixels covered by the area defined by the threshold and
the overall number of pixels in the image. The blood vascular area
in each placenta was estimated from the analysis of two non-
consecutive sections. The reported results correspond to individual
pregnant females and represent the average result for 2-3
placentas.
RNA isolation and chemokine gene expression
Total RNA from freshly collected placentas was obtained using
an RNeasy Mini Kit (Qiagen), following the manufacturer
protocol for animal tissues. One microgram of total RNA was
converted to cDNA (Transcriptor First Strand cDNA Synthesis
Kit, Roche) using random hexamer primers. MCP-1 (CCL2) and
MIP-1 alpha (CCL3) expression was quantified using TaqMan
Gene Expression Assays from ABI (Mm00441242_m1 and
Mm00441258_m1, respectively) with TaqMan Universal PCR
master mix. The gene expression quantification reactions were
performed in an ABI Prism 7900HT system. Relative quantifica-
tion of MCP-1 (CCL2) and MIP-1 alpha (CCL3) in each real-time
PCR reaction was obtained after normalization for GAPDH
expression measured in the same PCR reaction.
Synchronization of parasitized erythrocytes
iRBC were collected from infected animals with 10–20%
parasitemia. In order to obtain mature blood stage parasite forms
(trophozoites/schizonts), P. berghei ANKA-GFP infected erythro-
cytes were synchronized as described elsewhere [39]. After mature
forms enrichment, infected erythrocytes were resuspended in 1%
BSA in PBS at a concentration of 10
8 iRBC/ml.
Cytoadherence assays
Placentas from uninfected BALB/c females, obtained at G19,
were treated using a previously described protocol [40]. Briefly,
the placentas were fixed in 2% formalin and 0.5% glutaraldehyde
for 10 minutes, heated in a microwave oven before being paraffin-
embeded, and cut into sections of 5 mm onto glass slides. This
fixation protocol aims to preserves the binding capacity of
glycosylaminoglycans (GAG) in the placenta intervillous spaces
[40]. Tissue sections, after deparaffinized and rehydrated, were
delimitated with a DAKO pen. For placenta-receptor cleavage
experiments, placental sections were incubated with 0.5 U/ml
chondroitinase ABC (from Proteus vulgaris, Sigma), with 30 mg/ml
hyaluronidase (from bovine tests, Sigma), with heparinase II (from
Flavobacterium heparinum, Sigma) or with PBS for 2 periods of
2 hours at 37uC. Both enzyme-treated sections and non-treated
sections were blocked with 1% BSA in PBS at room temperature
for 30 minutes. Fifty microliters of synchronized iRBC suspension,
at the concentration of 10
8/ml, were overlaid onto each tissue
section for 60 minutes at 37uC in a humid chamber. After washing
the unbound cells, the placental sections were incubated with
DAPI. For iRBC-ligand blocking experiments, synchronized
iRBC were preincubated with the indicated concentrations of
chondroitin sulfate A (CSA) from bovine trachea (Sigma),
hyaluronic acid (HA) potassium salt from human umbilical cord
(Sigma) or colominic acid sodium salt (as negative control) from E.
coli (Sigma), at 37uC for 30 minutes with moderate agitation. For
iRBC-ligand cleavage assays iRBC were treated with trypsin
(Gibco), proteinase K (Sigma) or neuraminidase as a negative
control (from Clostridium perfringens, Sigma). iRBC were pre-
incubated with each enzyme at indicated concentrations for
30 minutes at 37uC. After washing, iRBC were overlaid on
placental sections as described above. The slides were mounted
with Mowiol and examined under fluorescence microscopy
(magnification 640). The number of iRBC adhering placental
sections in each experimental condition was determined in a blind
fashion, counting 50 fields in each of 3 independent experiments.
Statistical analysis
Statistical differences between groups of mice used in this study
were evaluated by the Student’s t test. Mann-Whitney test was
used for morphometric data and Log Rank test for survival curves.
Results
Experimental model
Our search for an experimental model that recapitulates typical
pathology features of severe malaria in pregnancy revealed that
time of infection during pregnancy is critical to evidence poor
pregnancy outcome and fetal growth impairments. In fact,
infection at early stages led to premature pregnancy interruption
while infection at G13 allowed pregnancy to proceed to later
stages when fetal and placenta pathology became apparent and
resembled human PAM. Moreover, such pathological features
were exuberant in the experimental model here reported, which
used lethal P. berghei-GFP to infect BALB/c female mice that are
resistant to cerebral malaria, allowing progression of the disease to
hyperparasitemia states. Other parasite species/mouse strains
combinations were tested and we noted that P. chabaudi did not
elicit pronounced signs of placental malaria and C57Bl/6 and
DBA/2 mouse strains could not survive to P. berghei-GFP infection
long enough to exhibit typical manifestations of malaria in
pregnancy (data not shown).
Increased malaria susceptibility in pregnant mice
Comparison of P. berghei-GFP course of infection in pregnant
and non-pregnant females confirmed earlier findings that
pregnancy in mice confers an increased susceptibility to malaria
[26,27,33] and showed that pregnant mice experienced faster
increase in parasitemia as compared to non-pregnant females.
Parasitemia in pregnant mice was 55.4165.44% (mean6SE) on
day 7 post-infection as compared to 33.8363.47% in non-
pregnant mice (p=0.007) (Figure 1A). In addition, survival to
infection was reduced in pregnant mice, with all deaths occurring
between day 5 and day 10 post-infection (Figure 1B). In contrast,
the majority of non-pregnant infected females survived until day
20 post-infection and by day 30 all had succumbed to infection
Pregnancy Malaria in Mice
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pregnant infected mice was 7.5 and 20.5 days, respectively. These
results suggest that, similarly to humans, pregnant mice show
increased susceptibility to malaria infection which may affect their
progeny or compromise pregnancy.
Unsuccessful pregnancy and impaired post-natal growth
We followed-up pregnancy outcome in 22 infected females and
found out that malaria had a strong negative effect in pregnancy
success (Table 1). Approximately two-thirds of infected pregnant
females (14 out of 22) did not give rise to viable pups due to
maternal death before parturition (8 cases) or to preterm delivery/
abortions (6 cases). The remaining mothers carried out pregnancy
to term giving rise to 27 viable newborns. The progeny of 2
infected mothers, out of 8 that gave birth, died after birth between
day 2 and day 21 (data not shown), indicating that malaria during
pregnancy increases pups mortality.
Post-natal growth of viable newborns was followed up to
weaning by weight monitoring and compared to 49 newborns
from non-infected mothers. In this experiment, infected mothers
would not survive long enough to nourish their pups and we used
foster mothers to feed all newborns as described in the methods
section. Low growth rate was observed in the majority of the
newborns from infected mothers (Figure 2A) resulting in obvious
body size discrepancy (Figure 2B). At day 10 after birth pups born
from infected mothers weighted significantly less (3.460.16 g) than
pups born from control mice (5.660.19 g) (Table 1), suggesting
that the growth impairment in the first stages of post-natal life may
result from intrauterine fetal growth impairment. Nevertheless,
those mice were able to develop until adulthood when they were
apparently normal (data not shown).
Fetal survival and intrauterine growth retardation
We evaluated the effects of malaria in pregnancy on fetal
survival and fetal growth at late pregnancy stages (G18) by
analyzing fetuses from 28 pregnant females infected at G13 and
from 9 non-infected pregnant females (Table 2). Uterus collected
at G18 from infected pregnancies frequently showed macroscopic
abnormalities, as compared to controls, corresponding to the
presence of aborted fetuses (Figure 3A). In fact, infected mothers
had significantly lower number of viable fetuses as compared to
non-infected mothers (p=0.01) and had higher number of aborted
fetuses (p=0.002) (Table 2).
We searched for signs of fetal impaired development in the
uterus. Fetuses from uninfected healthy mothers showed pink
coloration, had translucent skin with visible blood flow in the
blood vessels and the placentas were replenished with blood
(Figure 3B left and C). In contrast, many fetuses from infected
mothers appeared abnormal having remarkable reduced size, pale
tone with poor blood vessel replenishment and placentas with
reduced blood content (Figure 3B right and D). It is worth to
remark (Table 2) that average weight of viable fetus at G18 was
significantly lower in infected mothers (0.5560.034 g) as com-
pared to non-infected mothers (0.960.053 g). Together, these data
strongly suggest that fetuses from infected mothers suffer IUGR
and have decreased viability due to placenta blood flow
impairments, recapitulating pathological features of severe malaria
manifestations typically observed in pregnant women from low
malaria transmission regions [4].
Figure 1. Increased disease susceptibility in pregnant BALB/c
mice infected with P. berghei-GFP. BALB/c pregnant females were
infected on G13 by IV injection of 10
6 iRBC and non-pregnant females
were simultaneously infected. The plots represent cumulative results of
three independent experiments in a total of 32 pregnant and 16 non-
pregnant females. (A) Parasitemia curves where data points represent
mean6SE. From day 3 post-infection onwards parasitemia was
significantly higher in pregnant females (P-value,0.05). (B) Survival
curves up to 10 days after infection show that survival time of pregnant
female mice are significantly lower than in controls (P-value,0.0001). It
should be noted that non-pregnant females died at a later stage with
hyperparasitemia.
doi:10.1371/journal.pone.0001608.g001




















Infected 22 19.8 1.3 3.4 5 14(8/6)
Uninfected 14 20.7 1.4 5.6 6 0
p- value
(d) __ 0.05 0.03 ,0.0001 0.39 __
(a)BALB/c mothers were infected on G13 with P.berghei by IV injection of 10
6 iRBC and were allowed to give birth at term.
(b)Average values.
(c)Number of unsuccessful pregnancies (mother dead pregnant/preterm delivery or abortion).
(d)Student’s t test.
doi:10.1371/journal.pone.0001608.t001
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Placenta represents the interface between mother and fetus,
playing a critical role in fetal growth and development. Placental
tissue of infected pregnant females revealed a number of
abnormalities in comparison to non-infected controls (Figure 4).
We repeatedly observed significant thickening and disorganization
of labyrinthine zone, distension and disarrangements of perivas-
cular space (Figure 4D), as well as presence of parasitized red
blood cells in the maternal blood space (Figure 5A–C). Hemozoin,
a malaria parasite pigment, was observed in most of the infected
placentas (Figure 5B). Fetal blood circulation often contained
larger amount of erythroblasts (Figure 5D) but it never presented
any sign of parasites or hemozoin. Some specimens showed focal
fibrinoid necrosis in the placenta basal zone (Figure 4B),
hyperplasia of syncytiotrophoblastic cells (Figure 4D) and
accumulation of mononuclear cells in the maternal blood space
revealed by immunofluorescence staining. We evidenced accumu-
lation of CD11b expressing cells (Figure 6A), indicating that the
infiltrate was predominantly composed by monocytes/macro-
phages. This result prompted us to measure the expression of
macrophages attracting chemokines MIP-1 alpha and MCP-1 in
the placenta. RNA quantification revealed that MIP-1 alpha gene
expression was significantly increased in the infected placenta
(Figure 6C) providing support for the notion that cell and
molecular components of the innate immune system participate
in the host response to the placenta malaria infection.
Figure 2. Reduced growth rate in progenies of P. berghei-GFP
infected mothers. BALB/c pregnant females were infected on G13 by
IV injection of 10
6 iRBC. After delivery newborns were transferred to a
foster mother and their body weight was followed up to weaning (A).
Example of body size difference at day 21 of age is shown in (B), mouse
born from non-infected (left side) and from infected mother (right side).
doi:10.1371/journal.pone.0001608.g002
Figure 3. P. berghei-GFP infection impairs pregnancy outcome
and fetus development. (A) Representative uterus at G18 from BALB/
c pregnant females, uninfected (upper) and infected on G13 with P.
berghei-GFP by IV injection of 10
6 iRBC (bottom). The arrowheads
indicate abortions. (B) Fetus from uninfected (left) and from infected
mother (right). In detail, mouse placenta from an uninfected (C) and
infected mother (D). Lack of blood circulation is noticeable in the
placenta, paws and tail in panel (D). Scale bar represents 1 cm in A–B
and 0.5 cm in C–D.
doi:10.1371/journal.pone.0001608.g003
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The alterations in tissue organization observed in the infected
placenta suggested that the maternal blood flow could be reduced
in pregnancy malaria. Thus, we used a computerized morphom-
etry method to quantify cross-sectional areas of blood sinusoids in
placental labyrinthine region. Morphometric analysis was per-
formed as described in methods section and confirmed that the
blood sinusoids areas differed significantly between infected and
non-infected placentas. The average blood sinusoid area was
52.064.0 (mean6SD, arbitrary units) in the control group and it
dropped to 34.767.5 (p,0.0001) in the infected pregnant group
(Figure 7). The blood sinusoids area was measured in five different
regions of the labyrinthine zone and in all of them the area
decreased in similar degree, indicating that this phenomenon is
spread across the placenta rather than restricted to specific areas.
Together, the data suggest that alterations of pregnancy outcomes
observed in mice infected with P. berghei-GFP correlate with
pathological alterations of the placenta tissue, involving inflam-
mation, tissue disorganization, reduction of vascular spaces and
consequent reduction in blood supply.
iRBC binding to placental sections
Several receptors in human placenta have been suggested to
mediate P. falciparum cytoadhesion and sequestration and we
investigated the involvement of chondroitin sulfate A (CSA) and
hyaluronic acid (HA) in P. berghei-GFP iRBC cytoadhesion. Using
a set of ex vivo adhesion assays, we verified that CSA and/or HA
are involved in specific interactions of P. berghei-GFP blood stages
with the placental tissue (Figure 8). In fact, iRBC adherence was
significantly reduced if parasite mature forms were previously
incubated with CSA (Figure 8B) or HA (Figure 8C). Furthermore,
adhesion was competitively inhibited in a dose-dependent fashion
by both CSA (69% reduction at 1mg/ml) and HA (80% reduction
at 1mg/ml) , but not with colominic acid (Figure 8D, upper). In
addition, iRBC adherence also registered a significant reduction
on tissue sections pre-treated with chondroitinase (66% reduction)
or hyaluronidase (74% reduction), but heparinase had no effect on
the iRBC adhesion (Figure 8D, middle). With the aim of
demonstrating that adhesion properties of iRBC were dependent
on surface proteins, we pre-treated iRBC with two proteolytic
enzymes (trypsin and proteinase K) and a non-proteolic control





















Infected 28 521 0.6 2.4 1.7 3.7
Uninfected 9 102 1.0 0.2 0.7 7.7
p-value
(d) __ 0.02 ,0.0001 0.002 0.11 0.01
(a)BALB/c mothers were infected G13 with P.berghei by IV injection of 10
6 iRBC.




Figure 4. Placenta pathology in infected pregnant mice.
Histology of infected placentas collected at G18. HE stained sections
from non-infected mice (panels A and C) and infected (panels B and D)
are depicted. Different cell types are identified in panel A as (DC)
decidual cells, (Cy) cytotrophoblastic cells and (La) labyrinthic cells.
Fibrinoid necrosis areas (Ne) are indicated in panel B. Arrowhead in D
shows syncytiotrophoblast tissue thickening. Scale bar represents 100
mm in (A–B), and 10 mm in (C–D).
doi:10.1371/journal.pone.0001608.g004
Figure 5. Placental malaria. HE stained placentas from BALB/c
females infected with P. berghei-GFP and collected at G18. (A) Image
from severely infected placenta with high number of parasitized
maternal erythrocytes. (B) The same field as (A) under polarization
microscopy revealing hemozoin parasite pigment. (C) Arrowhead and
insert show an infected erythrocyte adhered to the syncytiotrophoblast
layer. (D) Placental section with infected erythrocytes (arrowhead) in the
maternal blood and fetal erythroblasts that were enhanced in the insert.
Scale bar represents 30 mm in (A, B and D) and 20 mm in (C).
doi:10.1371/journal.pone.0001608.g005
Pregnancy Malaria in Mice
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proteins showed to reduce adhesion capacity in a concentration-
dependent manner (Figure 8D, bottom). These results demon-
strate that P. berghei iRBC adhesion is partially dependent on the
presence of CSA and HA receptors in the placenta and is inhibited
by blocking their putative ligands in P. berghei-GFP iRBC. These
findings strongly suggest that CSA and HA in the mouse placental
tissue participate in adhesion of iRBC and may be involved in
parasite sequestration and in the consequent triggering the
placenta pathology events associated to malaria.
Discussion
Here we described pathological manifestations resembling
human malaria in pregnancy that were identified in a mouse
model that uses P. berghei-GFP. Accordingly to Desowitz [23], the
attributes of an experimental model of malaria in pregnancy
should account for superior parasitemia and virulence for the
mothers, when compared to non pregnant controls, and harmful
consequences for the fetuses. Preferably, such an experimental
model would show reasonable pathogenesis congruency to human
disease characteristics particularly in relation to placental
sequestration/cytoadherence properties. We showed that infecting
BALB/c mice with P. berghei-GFP during pregnancy results in
increased disease severity and impairments in fetal viability and
post-natal growth. These findings compel comparisons to the
placental damage and inflammation that are underlying the
clinical manifestations observed in humans [5–10]. Moreover,
cytoadherence assays support the hypothesis that P. berghei-GFP
iRBC encounter placental receptors that promote specific binding
in analogy to the proposed placenta sequestration mechanism for
P. falciparum [40,41].
In areas where malaria transmission is low or unstable, the levels
of immunization are weak or inexistent and PAM clinical
outcomes seem to be more severe for both to the mother and
fetus. The experimental model here presented was established in
non-immune mice, which enhanced disease severity and magnified
pathology phenotypes as compared to the human disease. Such
phenotypic exacerbation might be advantageous in identifying
molecular and cell host components playing key roles in the
pathogenesis mechanisms, leading to the different pathology
features observed in this experimental model of severe malaria
in pregnancy. Although P. falciparum infection in pregnant women
leads to lower parasitemia and is usually less severe as compared to
the mouse phenotypes here reported, it is worth mentioning that
primigravida women have been suggested to be more susceptible
to severe malaria in pregnancy because they did not experienced
previous contacts with parasites expressing antigens associated to
placental malaria [4,13]. On the other hand, studies on the
infection impact in immune pregnant mice are also needed and we
are building other experimental protocols that model the human
disease observed in epidemiological conditions of high malaria
transmission rate and high maternal pre-immunition.
Figure 6. Inflammatory infiltration and macrophage/monocyte
attractant chemokine expression in malaria infected placenta.
(A) Immunohistochemistry analysis of placentas from BALB/c females
infected on G13 with P. berghei-GFP iRBC and collected at G18 that
were stained with anti-GFP (green) and anti-CD11b (red) revealing the
presence of parasites on vascular walls and monocytes/macrophages
infiltration, respectively. The (B) panel represents sections of non
infected placentas. The cell nuclei were stained with DAPI (blue). Scale
bar represents 30 mm. (C) RNA expression of MIP-1 alpha and MCP-1
genes were quantified in 30 infected and 8 uninfected BALB/c placentas
collected on G18. Relative quantification was obtained by normalization
for GAPDH expression. Each bar represents the mean6standard error of
individual values. P-value=0.0002 is represented by ***.
doi:10.1371/journal.pone.0001608.g006
Figure 7. Reduction of placental vascular space in infected
pregnant mice. (A) The available area for blood circulation at G18 is
reduced in the case of infected placentas (A, right) in comparison with
non-infected (A, left). Scale bar represents 25 mm. (B) The placental area
occupied by blood sinusoids was quantified in relation to the total
placental area using an automated morphometric procedure, as
described in Materials and Methods (p,0.001, Mann Whitney Test).
doi:10.1371/journal.pone.0001608.g007
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as compared to non-pregnant mice as they experienced faster
increase in parasitemia and earlier death by hyperparasitemia
(Figure 1). A significant proportion of the infected pregnant
females most of the times abort, or even die before parturition, and
no progeny is observed (Table 1). Maternal pre-immunition has
been considered crucial for the disease severity, however hormonal
changes and immuno-depression could have an important
contribution to the observed increased susceptibility to infection
during pregnancy [42–46]. Polyclonal activation associated with
splenomegaly, hypergammaglobulinemia and immune-depression
is commonly observed in Plasmodium infections. The spleen is a
major site for Plasmodium clearance and its increased weight may
represent a sign of activation status of the immune system
revealing the presence of a current infection [47]. It is remarkable
that the spleen weight of infected pregnant females was increased 5
fold when compared to the uninfected controls (Table 2), possibly
representing an exacerbated activation of the maternal immune
system by P. berghei-GFP infection during pregnancy.
Human placenta pathology associated with P. falciparum
infection includes the following features: local parasitemia,
malarial pigment deposits, excess of fibrinoid deposits, syncytio-
trophoblast necrosis, trophoblast basement membrane thickening
and macrophage infiltration [48].
We noted that iRBC were in intimate contact with placental
tissue components and that hemozoin was widely spread in
maternal blood spaces of infected placentas. It has been argued
that hemozoin accumulates in tissue and within macrophages,
Figure 8. Ex vivo adherence of P. berghei-GFP iRBC to mouse placenta. (A) Typical microscopic image of adherence assays showing iRBC
adhered in the intervillous space and to syncytiotrophoblast cell layer (A). Representative images of blocking adherence assays where iRBC were pre-
incubated with 2 mg/ml of CSA (B) and HA (C). IRBC were preincubated with increasing concentrations of HA, CSA and colominic acid and then used
in binding assays as described in materials and methods (D, upper graph). Adhesion of iRBC to uninfected placental tissue pre-treated with
chondroitinase ABC and hyaluronidase but not with heparinase (D, middle graph). Intact iRBC were treated with neuraminidase, proteinase K and
trypsin prior incubation with the placental tissue (D, lower graph). All data represent the proportion of bound iRBC expressed as a percentage of
control (mean6s.e.m. for three experiments). P-value,0.001 is represented by ***.
doi:10.1371/journal.pone.0001608.g008
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placental function impairment and favoring immunodepression
[49,50]. We hypothesize that accumulation of P. berghei-GFP iRBC
in the placenta may evoke the inflammatory response that
resembles the placental malaria pathology attributed to P.
falciparum.
In response to the presence of iRBC, activated placental
macrophages could induce placental damage, through releasing
inflammatory cytokines such as TNF-a [51]. Hofbauer cells,
placental resident macrophages, can be stimulated by placental
parasites to produce b-chemokines that are chemotactic for
monocytes/macrophages. This is in line with our observation that
the chemokine MIP-1 alpha was upregulated in infected placentas.
Such type of inflammatory triggering would explain the observed
recruitment of a mononuclear infiltrate that predominate in
maternal blood spaces of the labyrinthine zone. Activated
macrophages could process and present antigens to maternal
lymphocytes that, in turn, produce inflammatory cytokines,
helping the parasite elimination [52,53].
P. berghei-GFP infected placentas showed general tissue archi-
tecture disorganization with prominent thickening of the syncy-
tiotrophoblast. This may result in part from fibrosis which has
been proposed to arise from the reparative process stimulated by
the response to infection [54]. It has been proposed that fibrinoid
deposition confers fetus protection from maternal immune
responses [55,56] possibly concealing fetal antigens from the
maternal immune system [55]. However, extensive fibrinoid
necrosis and fibrinoid deposition are abnormal and typical of
malaria infected placentas [51]. In our experimental model we
consistently found fibrinoid lesions that were restricted to the
maternal placental regions, either covering extensive areas or
having focal distribution.
A striking pathological finding in P. berghei-GFP infected
placentas was the reduction of blood sinusoids space (Figure 7),
which is attributable to placental tissue thickening that presumably
compressed available blood vascular space. The blood vascular
area was reduced by 32% as compared to non-infected placentas
implying an important placental blood volume reduction.
The effects of malaria on the newborn status are believed to be
caused by placental insufficiency [57]. In fact, blood flow
restrictions in infected placentas correlate well with fetal and
postnatal development impairments observed in progeny from
pregnant females infected with P. berghei-GFP (Figure 2). It is
known that babies born to anemic mothers have low iron stores
and are more likely to develop anemia [58]. Malaria in pregnancy
is frequently associated with infant anemia and, consequently,
child development and survival are at risk [59,60]. Pathologic
disorders may modify the intrinsic respiratory capacity of the
placenta at any given gestational age, due to fibrinoid deposition
that impairs gas diffusion, and to thickening that reduce the
capillary area for exchange and the placental blood flow [61].
Consequently these placental changes caused by malaria will lead
to insufficient in uterus hemoglobin/iron/oxygen availability and
nutrients supply associated with an excess number of fetal
circulating erythroblasts, which was consistent with our findings
(Figure 5D). Although we could not detect a significant increase in
Hypoxia-Inducible Factor-1alpha gene expression in infected
placentas (data not shown), it is likely that tissue stress responses
induced by the alterations in placenta blood circulation could play
a role in placental malaria physio-pathology. PAM detrimental
effects in mice offspring are somewhat diverse. Some fetuses
survived, others were underweight and several died inside the
uterus (Table 1 and Figure 3A). We observed lower birth weight in
the newborns from mothers infected during pregnancy when
compared to the ones from healthy mothers (p=0.03). This weight
difference was steadily maintained in post-natal life until weaning,
even if newborn mice from infected mothers were fostered by non-
infected mothers.
Although we have found important pathological changes in
both basal and labyrinthine zones of mouse placenta, parasites and
hemozoin were never visualized in the fetal circulation and
positive parasitemia was never recorded in newborns from infected
mothers. The absence of evidence for congenital infection, despite
the presence of numerous iRBC in the placental maternal blood,
points to the efficacy of the placental trophoblastic layer to block
parasite traversing to fetal blood. The mechanism by which the
trophoblastic cells prevent fetal infection is poorly understood, but
several trophoblast defense mechanisms have been proposed [62–
64]. These cells are not only able to perform phagocytosis in vivo
and in vitro but, when properly stimulated via IFNc, are also
capable of increasing erythrophagocytosis activity [65].
The pattern of iRBC adherence in P. falciparum infected
placentas remains controversial, but the main placental candidate
receptors and their cognate parasite ligands participating in iRBC
adhesion have been identified. Muthusamy et al. [40] established
that the major natural receptors for iRBC adherence are localized
primarily in the intervillous space of the placenta and at a lower
extent on the syncytiotrophoblasts. It is known that iRBC bind
different host molecules present in several organs, but CSA and
HA have been suggested as mediators of parasite accumulation in
the placenta [66]. CSA molecules from different sources differ in
sulfatation patterns, with major consequences for iRBC adhesion
[67,68]. Highly sulfated forms can fail to support adhesion,
whereas low-sulfated forms are optimal for binding [69,70] and
appear on the syncytiotrophoblast and in intervillous spaces [70].
HA has also been proposed as a candidate placental receptor [16],
but its role in parasite adhesion is still debated [71,72].
Our data show a significant reduction of placental adhesion
when the iRBC were pre-incubated with of soluble HA (up to 90%
reduction, compared to control) or CSA (up to 75% reduction,
compared to control), indicating that these GAG can be important
adhesion receptors in this model. Chondroitinase and hyaluron-
idase placental sections treatment also reduced adhesion consid-
erably but did not completely abrogate binding. This is in line with
P. falciparum previous studies demonstrating that the placental
parasite populations do not adhere in a uniform manner to
immobilized CSA or GAG receptors, implying that other factors
may be confounding this interaction or other receptors are
involved [73].
To demonstrate that the iRBC binding is receptor dependent,
we treated iRBC with two different proteases and showed that
binding properties of protease-treated iRBC were substantially
inhibited, which was consistent with the involvement of surface
membrane protein receptors in mediating adhesion. The P. berghei-
GFP adhesion to CSA and HA indicates that iRBC could co-
express ligands for different receptors, represented either by
separate adhesive molecules or by different binding sites on a
single molecule. Overall, the experimental data suggest that
cytoadherence of P. berghei-GFP in the placenta may involve CSA
and HA as receptors and raises the hypothesis that human and
murine malaria in pregnancy have similar pathogenesis basis.
Future efforts towards collecting in vivo evidence for iRBC
binding will help to further establish CSA and HA as key
pathogenesis mediators in placental malaria.
The phenotypic characterization of murine PAM here present-
ed warrants that further research is needed to describe the
pathogenesis mechanisms at cell and molecular levels. Although
PfEMP1 orthologues were not yet found in P.berghei, our findings
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adhesion in the mouse placenta could have in P.berghei iRBC
cognate ligands that are related to PfEMP1. The prominent
histological alterations in mouse placenta heavily infected with P.
berghei-GFP resemble those described for acute P. falciparum malaria
in humans [57], and future lines of research will clarify whether
pathogenesis components, already identified in humans, have their
counterpart in this model of severe malaria in pregnancy. Genetic
manipulations of the model will offer opportunities to identify
further host pathogenesis factors involved in placenta pathology.
Thus, the experimental model here described may offer new
opportunities to investigate the mechanisms implicated in
placental malaria and in pregnancy outcome impairments, which
are difficult to study in human subjects.
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